Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27917597)

Published in J Viral Hepat on December 05, 2016

Authors

N Durier1, E Yunihastuti2,3, K Ruxrungtham4,5, N V Kinh6, A Kamarulzaman7, D Boettiger8, A Widhani2,3, A Avihingsanon4,5, B V Huy6, S F B Syed Omar7, A Sanityoso2,3, S Chittmittrapap5, N T H Dung6, V Pillai9, T Suwan-Ampai1, M Law8, A H Sohn1, G Matthews8

Author Affiliations

1: TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
2: Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
3: Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
4: HIVNAT, the Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
5: Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
6: National Hospital of Tropical Diseases, Hanoi, Vietnam.
7: University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
8: The Kirby Institute, UNSW Australia, Sydney, NSW, Australia.
9: Faculty of Medicine, Centre of Excellence for Research in AIDS (CERiA), University of Malaya, Kuala Lumpur, Malaysia.

Articles cited by this

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat (2006) 5.10

Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol (2014) 4.82

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol (1997) 4.08

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology (2008) 3.47

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. J Infect Dis (2008) 2.72

Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol (2005) 2.27

Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study. Lancet Infect Dis (2014) 1.88

Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut (2010) 1.77

Frequent multiple hepatitis C virus infections among injection drug users in a prison setting. Hepatology (2010) 1.77

Higher clearance of hepatitis C virus infection in females compared with males. Gut (2006) 1.57

Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis (2016) 1.47

All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection. J Hepatol (2012) 1.16

Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C. BMC Med (2013) 1.16

Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy. Clin Infect Dis (2012) 1.08

Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs. Hepatology (2014) 1.08

High prevalence of HBV and HCV infection among intravenous drug users in Korea. J Med Virol (2008) 1.08

Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C. Hepatology (2008) 1.04

Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index. J Infect Dis (2010) 1.03

High prevalence of Hepatitis C virus genotype 6 in Vietnam. Asian Pac J Allergy Immunol (2009) 1.02

Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variants. PLoS One (2012) 1.01

Very high prevalence of hepatitis C virus genotype 6 variants in southern Vietnam: large-scale survey based on sequence determination. Jpn J Infect Dis (2011) 1.00

The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection. Gut (2009) 1.00

A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study. J Viral Hepat (2008) 0.95

Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3. PLoS One (2012) 0.94

Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review. Dig Dis Sci (2015) 0.91

Hepatitis C, a global issue: access to care and new therapeutic and preventive approaches in resource-constrained areas. Semin Liver Dis (2014) 0.91

Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam. J Med Virol (2010) 0.91

Seroepidemiology and genotypes of hepatitis C virus in Thailand. Asian Pac J Allergy Immunol (2007) 0.91

Impact of Il28b-related single nucleotide polymorphisms on liver transient elastography in chronic hepatitis C infection. PLoS One (2013) 0.89

Molecular epidemiology and genetic history of hepatitis C virus subtype 3a infection in Thailand. Intervirology (2013) 0.89

Spontaneous Clearance of the Hepatitis C Virus Among Men Who Have Sex With Men. Clin Infect Dis (2015) 0.88

Genotype diversity of hepatitis C virus (HCV) in HCV-associated liver disease patients in Indonesia. Liver Int (2010) 0.87

Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels. J Gastroenterol Hepatol (2014) 0.87

The genetic diversity and evolutionary history of hepatitis C virus in Vietnam. Virology (2014) 0.87

Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia. PLoS One (2015) 0.87

Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings. J Hepatol (2014) 0.86

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients. HIV Med (2014) 0.86

Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis. Int J Drug Policy (2015) 0.84

Genotypic analysis of hepatitis C virus in blood donors in Indonesia. Am J Trop Med Hyg (2000) 0.81

Hepatitis C genotype and associated risks factors of patients at University Kebangsaan Malaysia Medical Centre. Pak J Med Sci (2013) 0.80

Hepatitis C virus clearance and gender. Gut (2007) 0.80

Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection. J Gastroenterol Hepatol (2014) 0.78

Genotype 3 is the predominant hepatitis C genotype in a multi-ethnic Asian population in Malaysia. Hepatobiliary Pancreat Dis Int (2015) 0.76